CME Internet Symposium

About the Program

• Program Overview
• Target Audience
• Learning Objectives
• Faculty
• Physician Continuing Medical Education
• Disclosure of Conflicts of Interest
• Instructions for Participation and Credit
• Disclosure of Unlabeled Use
• Disclaimer
• Computer System Requirements

Program Overview

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 23rd International AIDS Conference (AIDS 2020). This program consists of four components: (1) From Conference to Clinic: Reviewing and Applying Data from AIDS 2020: a case-based on-line webcast featuring expert faculty reviewing key presentations with a focus on clinical management and treatment; (2) CME Internet Symposium: AIDS 2020 Expert Review:** an Internet symposium that features an overview of key presentations and posters, selected by the expert faculty; (3) Rapid-Fire Review of AIDS 2020:** a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (4) AIDS 2020 e-Newsletter: a brief on-line summary of the most essential data presented at the conference.

The CME Internet Symposium: From Conference to Clinic: Reviewing and Applying Data from AIDS 2020 will feature a panel of HIV experts reviewing key presentations on antiretroviral therapy presented at AIDS 2020. The review will include several clinical cases focusing on HIV therapeutic options and developments, including: current treatment and management strategies; algorithms and recommendations; therapies in development; epidemiology, diagnosis and clinical management of specific patient populations. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All on-line components of the program can be accessed at www.viraled.com.

This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine. It is not a session created by or presented at AIDS 2020 and it is not sanctioned by the organizers of AIDS 2020.

**These components are produced by the Postgraduate Institute for Medicine and ViralEd, Inc and supported by an independent educational grant from Gilead Sciences Medical Affairs.

Back to Top

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives

After completing this activity, the participant should be better able to:

• Explain the epidemiology of HIV today
• Initiate ARV therapy rapidly following an HIV diagnosis
• Select optimal ARV therapy to all people with HIV infection
• Identify the risk and causes of ARV resistance and learn how to reduce this risk through appropriate ARV regimen selection
• Assess the impact of ARV adverse events on treatment success and be able to adjust ARV regimens to maximize tolerability
• Recognize ARV adverse effects, especially neuropsychiatric effects and weight gain, and adjust ARV regimens to minimize these effects
• Recognize mental health issues, such as stress, anxiety, depression, and substance use, in patients being treated for HIV infection, and employ approaches for addressing these mental health issues

Release Date: July 30, 2020

Expiration Date: July 30, 2021

Estimated time to complete the program: 15-30 minutes per module

Media: Internet

Back to Top

Faculty

José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain

Marta Boffito, MD, PhD
St. Stephen's AIDS Trust and Imperial College
Chelsea and Westminster Hospital
London, United Kingdom

Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom 

Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine
University Hospital
Bonn, Germany

Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois 

Back to Top

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

For Each Program Module

Clinical Cases on Prevention Module:
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Clinical Cases in Pregnancy and Treatment-Naive Patients Module:
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Clinical Cases in Treatment-Experienced Patients Module: 
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Clinical Cases in Hepatitis and COVID-19 in HIV Co-infections Module:
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Clinical Cases in Pharmacology Module:
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Clinical Cases on Adverse Effects and Co-morbidities Module: 
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to The Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Annenberg Center for the Health Sciences at Eisenhower staff involved in this activity have no relevant commercial relationships to disclose.

The PIM planners and managers have nothing to disclose.

The ViralEd planners and managers have nothing to disclose. 

Back to Top

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this activity.  During the period, July 30, 2020 through July 30, 2021, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment of completing this activity, please complete the evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 15308. Upon registering and successfully completing the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 

Back to Top

Computer System Requirements

This program requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable version of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player and Real Networks Real One Player. 

Back to Top

Back to Top